Chon-kit Chou

State Key Laboratory Of Quality Research In Chinese Medicine
Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Decoding TNF receptor superfamily control of CD4+Foxp3+ Regulatory T cell-mediated tolerance: implications for the treatment of graft‑versus‑host disease.

Decoding TNF receptor superfamily control of CD4+Foxp3+ Regulatory T cell-mediated tolerance: implications for the treatment of graft‑versus‑host disease.

Journal: Cell communication and signaling : CCS

Published: February 03, 2026

Ubiquitin-specific proteases: Key regulators in TLR/IL-1R signaling and inflammatory disease progression.

Ubiquitin-specific proteases: Key regulators in TLR/IL-1R signaling and inflammatory disease progression.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 19, 2026

A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.

A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.

Journal: Frontiers in immunology

Published: September 01, 2025

Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention.

Deubiquitinating enzymes: Key regulators of ferroptosis and pyroptosis and novel targets for cancer intervention.

Journal: International journal of biological sciences

Published: February 10, 2025

miR-125b-5p sensitizes colorectal cancer to anti-PD-L1 therapy by decreasing TNFR2 expression on tumor cells.

miR-125b-5p sensitizes colorectal cancer to anti-PD-L1 therapy by decreasing TNFR2 expression on tumor cells.

Journal: Journal of leukocyte biology

Published: February 07, 2025

TRIP13 promotes the expansion and immunosuppression of CD4+Foxp3+ regulatory T cells by sustaining HAT1 stability.

TRIP13 promotes the expansion and immunosuppression of CD4+Foxp3+ regulatory T cells by sustaining HAT1 stability.

Journal: Cell death & disease

Published: February 04, 2025

USP15 Drives NSCLC Progression and Chemoresistance, Potentially via Regulation of the U2-Type Spliceosomal Complex.

USP15 Drives NSCLC Progression and Chemoresistance, Potentially via Regulation of the U2-Type Spliceosomal Complex.

Journal: Cancer medicine

Published: January 08, 2025

Pre-ligand assembly domain-derived recombinant protein of TNFR2 inhibits the expansion of CD4+ Foxp3+ regulatory T cells.

Pre-ligand assembly domain-derived recombinant protein of TNFR2 inhibits the expansion of CD4+ Foxp3+ regulatory T cells.

Journal: Journal of leukocyte biology

Published: December 06, 2024

Anti-tumor necrosis factor therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells.

Anti-tumor necrosis factor therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells.

Journal: Journal of leukocyte biology

Published: October 17, 2024

Anti-TNFR2 Antibody-Conjugated PLGA Nanoparticles for Targeted Delivery of Adriamycin in Mouse Colon Cancer.

Anti-TNFR2 Antibody-Conjugated PLGA Nanoparticles for Targeted Delivery of Adriamycin in Mouse Colon Cancer.

Journal: Research (Washington, D.C.)

Published: May 27, 2024

Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.

Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.

Journal: Cell communication and signaling : CCS

Published: February 26, 2024

Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy.

Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy.

Journal: Pharmaceutics

Published: January 19, 2023

Showing 1-12 of 35

Last Updated: 09/26/2026